Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations
Authors
Keywords
Opioid use disorder, Buprenorphine, Treatment, Long-acting injectables
Journal
PREVENTIVE MEDICINE
Volume -, Issue -, Pages 106756
Publisher
Elsevier BV
Online
2021-08-02
DOI
10.1016/j.ypmed.2021.106756
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine
- (2020) Nicole Brunet et al. Substance Abuse
- Trends in Infective Endocarditis Hospitalizations, Characteristics, and Valve Operations in Patients With Opioid Use Disorders in the United States: 2005–2014
- (2020) Makoto Mori et al. Journal of the American Heart Association
- Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
- (2020) Theresa Winhusen et al. Contemporary Clinical Trials
- Geographic proximity to buprenorphine treatment providers in the U.S.
- (2020) James R. Langabeer et al. DRUG AND ALCOHOL DEPENDENCE
- Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
- (2020) Kathryn F. Hawk et al. JAMA Network Open
- Signal of increased opioid overdose during COVID-19 from emergency medical services data
- (2020) Svetla Slavova et al. DRUG AND ALCOHOL DEPENDENCE
- Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic
- (2020) Taylor A. Ochalek et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- When Prescribing Isn’t Enough — Pharmacy-Level Barriers to Buprenorphine Access
- (2020) Hannah L.F. Cooper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Cascade of Care for responding to the opioid epidemic
- (2019) Arthur Robin Williams et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Barbara R Haight et al. LANCET
- Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections
- (2019) Laura C Fanucchi et al. CLINICAL INFECTIOUS DISEASES
- U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018
- (2019) Robin Ghertner DRUG AND ALCOHOL DEPENDENCE
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
- (2018) Marc R. Larochelle et al. ANNALS OF INTERNAL MEDICINE
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder
- (2018) Michelle R. Lofwall et al. JAMA Internal Medicine
- Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System
- (2018) Traci C. Green et al. JAMA Psychiatry
- Substance Use Disorder Assessment, Diagnosis, and Management for Patients Hospitalized With Severe Infections Due to Injection Drug Use
- (2018) Crystal Jicha et al. Journal of Addiction Medicine
- Buprenorphine Pharmacology Review
- (2018) Marion A. Coe et al. Journal of Addiction Medicine
- Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians
- (2018) C. Holly A. Andrilla et al. JOURNAL OF RURAL HEALTH
- Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs
- (2018) Andrea K. Finlay et al. Journal of Studies on Alcohol and Drugs
- Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention
- (2017) Gail D’Onofrio et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder
- (2017) Sharon L. Walsh et al. JAMA Psychiatry
- Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center
- (2016) Michael S. Toce et al. CLINICAL TOXICOLOGY
- County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States
- (2016) Michelle M. Van Handel et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Putting Parity into Practice — Integrating Opioid-Use Disorder Treatment into the Hospital Setting
- (2016) Laura Fanucchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
- (2016) Philip J. Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence
- (2015) Gail D’Onofrio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Needle Fixation Profile: An Exploratory Assessment of Applicability in the Australian Context
- (2015) Scott Hinton et al. SUBSTANCE USE & MISUSE
- A Review of Buprenorphine Diversion and Misuse
- (2014) Michelle R. Lofwall et al. Journal of Addiction Medicine
- Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients
- (2014) Jane M. Liebschutz et al. JAMA Internal Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search